Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

17%(1 trials)

Phase Distribution

Ph not_applicable

17%

Ph phase_2

17%

Ph phase_1

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

4(66.7%)

Phase 2Efficacy & side effects

1(16.7%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 14 (66.7%)

Phase 21 (16.7%)

N/A1 (16.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_1

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

completednot_applicable

Effects of an 8-day Advanced Meditation, Samyama on Physical, Psychological and Spiritual Wellbeing ,and Associated Neural Mechanisms

NCT04366544

completedphase_1

Clinical Trials (6)

Showing 6 of 6 trials

NCT03474640Phase 1

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Completed

NCT04366544Not Applicable

Effects of an 8-day Advanced Meditation, Samyama on Physical, Psychological and Spiritual Wellbeing ,and Associated Neural Mechanisms

Completed

NCT05082051Phase 1

Oral CDX-7108 in Healthy Adults and EPI Subjects

Completed

NCT04510649Phase 1

Surufatinib DDI With a PPI and a CYP3A Inducer

Completed

NCT01929629Phase 1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914

Completed

NCT00291928Phase 2

HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6